DỊCH CHIẾT CỦA CÂY OROXYLUM INDICUM (L.) KURZ ỨC CHẾ SỰ TĂNG SINH VÀ CẢM ỨNG APOPTOSIS ĐỐI VỚI TẾ BÀO UNG THƯ GAN HEPG2 THÔNG QUA ĐIỀU CHỈNH SỰ SẢN SINH ROS
Thông tin bài báo
Ngày nhận bài: 06/11/24                Ngày hoàn thiện: 21/01/25                Ngày đăng: 22/01/25Tóm tắt
Từ khóa
Toàn văn:
PDF (English)Tài liệu tham khảo
[1] C. E. Weeden, W. Hill, E. L. Lim, E. Grönroos, and C. Swanton, “Impact of risk factors on early cancer evolution,” Cell, vol. 186, no. 8, pp. 1541-1563, Apr. 2023, doi: 10.1016/j.cell.2023.03.013.
[2] R. L. Siegel, A. N. Giaquinto, and A. Jemal, “Cancer statistics, 2024,” CA. Cancer J. Clin., vol. 74, no. 1, pp. 12-49, Jan. 2024, doi: 10.3322/caac.21820.
[3] S. R. Bonam et al., “What Has Come out from Phytomedicines and Herbal Edibles for the Treatment of Cancer?,” ChemMedChem, vol. 13, no. 18, pp. 1854-1872, Sep. 2018, doi: 10.1002/cmdc.201800343.
[4] H. Yang, L. Wang, and J. Zhang, “Leukocyte modulation by natural products from herbal medicines and potential as cancer immunotherapy,” J. Leukoc. Biol., vol. 112, no. 1, pp. 185-200, Jun. 2022, doi: 10.1002/JLB.3RU0222-087RRR.
[5] J. Zhang, Y. Wu, Y. Tian, H. Xu, Z.-X. Lin, and Y.-F. Xian, “Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications,” Mol. Cancer, vol. 23, no. 1, p. 217, Oct. 2024, doi: 10.1186/s12943-024-02135-3.
[6] B. Chiraatthakit, B. Dunkunthod, S. Suksaweang, and G. Eumkeb, “Antiproliferative, Antiangiogenic, and Antimigrastatic Effects of Oroxylum indicum (L.) Kurz Extract on Breast Cancer Cell,” Evid. Based Complement. Alternat. Med., vol. 2023, no. 1, p. 6602524, Jan. 2023, doi: 10.1155/2023/6602524.
[7] A. R. Singh et al., “Bioassay-Guided Isolation of 2-[p-(2-Carboxyhydrazino)phenoxy]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol from Oroxylum indicum and the Investigation of Its Molecular Mechanism Action of Apoptosis Induction,” Pharmaceuticals, vol. 15, no. 5, p. 559, Apr. 2022, doi: 10.3390/ph15050559.
[8] X. Luo et al., “Effect of Oroxylum indicum on hepatocellular carcinoma via the P53 and VEGF pathways based on microfluidic chips,” BMC Complement. Med. Ther., vol. 23, no. 1, p. 400, Nov. 2023, doi: 10.1186/s12906-023-04217-z.
[9] T. T. H. Le, M. Q. Nguyen, V. P. Nguyen, V. H. Hoang, and P. H. Nguyen, “Methanol Extract of Ficus pumila L. Inhibits Proliferation, Induces Apoptosis and Arrests the Cell Cycle in HepG2 Live Cancer Cells,” Asian J. Plant Sci., vol. 22, no. 3, pp. 423-433, Jun. 2023, doi: 10.3923/ajps.2023.423.433.
[10] T. T. H. Le, T. H. Ngo, T. H. Nguyen, V. H. Hoang, V. H. Nguyen, and P. H. Nguyen, “Anti-cancer activity of green synthesized silver nanoparticles using Ardisia gigantifolia leaf extract against gastric cancer cells,” Biochem. Biophys. Res. Commun., vol. 661, pp. 99-107, Jun. 2023, doi: 10.1016/j.bbrc.2023.04.037.
[11] B. Buranrat, S. Noiwetch, T. Suksar, and A. Ta-ut, “Inhibition of cell proliferation and migration by Oroxylum indicum extracts on breast cancer cells via Rac1 modulation,” J. Pharm. Anal., vol. 10, no. 2, pp. 187-193, Apr. 2020, doi: 10.1016/j.jpha.2020.02.003.
[12] B. Buranrat and S. Boontha, “The seed extract of Oroxylum indicum suppresses cell proliferation, migration and promotes apoptosis in cervical cancer cells,” Pak. J. Pharm. Sci., vol. 35, no. 2, pp. 553-559, Mar. 2022.
[13] S. Kameyanda Poonacha et al., “Insight into OroxylinA-7-O-β-d-Glucuronide-Enriched Oroxylum indicum Bark Extract in Oral Cancer HSC-3 Cell Apoptotic Mechanism: Role of Mitochondrial Microenvironment,” Molecules, vol. 26, no. 24, p. 7430, Dec. 2021, doi: 10.3390/molecules26247430.
[14] D. R. N. Kumar, V. C. George, P. K. Suresh, and R. A. Kumar, “Cytotoxicity, Apoptosis Induction and Anti-Metastatic Potential of Oroxylum indicum in Human Breast Cancer Cells,” Asian Pac. J. Cancer Prev., vol. 13, no. 6, pp. 2729-2734, Jun. 2012, doi: 10.7314/APJCP.2012.13.6.2729.
[15] S. Lodh and M. K. Swamy, “Oroxylum indicum Vent. and Its Bioactive Compound, Baicalein Against Cancer Cells: Mechanisms of Action,” in Plant-derived Bioactives, M. K. Swamy, Ed., Singapore: Springer Singapore, 2020, pp. 441-454, doi: 10.1007/978-981-15-2361-8_20.
[16] S. J. Kim, H. S. Kim, and Y. R. Seo, “Understanding of ROS-Inducing Strategy in Anticancer Therapy,” Oxid. Med. Cell. Longev., vol. 2019, pp. 1-12, Dec. 2019, doi: 10.1155/2019/5381692.
[17] C. Glorieux, S. Liu, D. Trachootham, and P. Huang, “Targeting ROS in cancer: rationale and strategies,” Nat. Rev. Drug Discov., vol. 23, no. 8, pp. 583-606, Aug. 2024, doi: 10.1038/s41573-024-00979-4.
[18] Q. Qian et al., “Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine,” Oxid. Med. Cell. Longev., vol. 2019, pp. 1-23, Sep. 2019, doi: 10.1155/2019/9240426.DOI: https://doi.org/10.34238/tnu-jst.11490
Các bài báo tham chiếu
- Hiện tại không có bài báo tham chiếu





